Independent register of U.S. FDA drug recalls · updated Oct 12, 2026
RxRecalls Get alerts

Class II drug recalls - moderate risk

Class II means the product may cause temporary or medically reversible harm, and serious harm is unlikely. It is by far the largest recall class - most potency, dissolution and labeling problems land here.

14,535 recalls, newest first.

Class II · Moderate risk

Serum 50% BSS 50% Opth Drops

Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.

Terminated Sterility / contamination Health Innovations Pharmacy, Inc D-1009-2015
Class II · Moderate risk

EDTA 3% Eye Drops

Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.

Terminated Sterility / contamination Health Innovations Pharmacy, Inc D-1008-2015
Class II · Moderate risk

Glycerin 98.5% Opth. Solution

Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.

Terminated Sterility / contamination Health Innovations Pharmacy, Inc D-1007-2015
Class II · Moderate risk

Fortifed Tobramycin 15 mg/1 mL Opth.

Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.

Terminated Sterility / contamination Health Innovations Pharmacy, Inc D-1006-2015
Class II · Moderate risk

Dexamethasone 4 mg/mL Iontophoresis

Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.

Terminated Sterility / contamination Health Innovations Pharmacy, Inc D-1005-2015
Class II · Moderate risk

Trimix #1 (Original)

Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.

Terminated Sterility / contamination Health Innovations Pharmacy, Inc D-1004-2015
Class II · Moderate risk

Laureth-P 1% Injection

Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.

Terminated Sterility / contamination Health Innovations Pharmacy, Inc D-1003-2015
Class II · Moderate risk

Sodium Tetradecyl 1% Injection

Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.

Terminated Sterility / contamination Health Innovations Pharmacy, Inc D-1002-2015
Class II · Moderate risk

Methylcobalamin 1000 mcg/mL Injection

Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.

Terminated Sterility / contamination Health Innovations Pharmacy, Inc D-1001-2015
Class II · Moderate risk

Cyanocobalamin 2000mcg/1ml Injection

Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.

Terminated Sterility / contamination Health Innovations Pharmacy, Inc D-1000-2015
Class II · Moderate risk

HCG 1000 Units/mL Injection

Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.

Terminated Sterility / contamination Health Innovations Pharmacy, Inc D-0999-2015
Class II · Moderate risk

17-HP Hydroxyprogesterone 250mg/1ml Injection

Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.

Terminated Sterility / contamination Health Innovations Pharmacy, Inc D-0998-2015
Class II · Moderate risk

Mafenide Acetate

Presence of Foreign Substance; oxidized steel, organic material and shredded polypropylene

Terminated Particulate / foreign matter Par Pharmaceutical Inc. NDC 49884-902-52 D-0393-2015
Class II · Moderate risk

Erythromycin Pledgets USP

Microbial Contamination of Non-Sterile Products: Active Pharmaceutical Ingredient (API) failed USP microbial tests.

Terminated Microbial contamination Akorn, Inc. NDC 61748-202-60 D-0385-2015
Class II · Moderate risk

Compounded Plaquex

Good Manufacturing Practices Deviations: The product has an active pharmaceutical ingredient from an unapproved source.

Terminated Unapproved drug AnazaoHealth Corporation D0384-2015
Class II · Moderate risk

Levetiracetam

Failed Dissolution Specifications: 6 month time point.

Terminated Dissolution failure Sun Pharma Global Fze D-0386-2015
Class II · Moderate risk

Benzonatate Capsules

Failed Tablet/Capsule Specifications; recall initiated by manufacturer due to reports of wet capsules

Terminated Failed specification American Health Packaging NDC 68084-214-01 D-0430-2015

Recalls by year